Global Osteoporosis Drugs Market is expected to grow at a CAGR of 5.53% during the forecast period from 2019-2025

As per the report published by Fior Markets, the global osteoporosis drugs market is expected to grow from USD 1,434.17 Billion in 2017 to USD 1,816.27Billion by 2025 at a CAGR of 5.53% during the forecast period from 2018-2025. The presence of well-established medical & healthcare infrastructure, substantial investments in the healthcare activities, favorable R& D policies of the government towards the osteoporosis drug applications are the major trends for the increasing osteoporosis drugs market in North America region.

Osteoporosis Drugs Market by Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, Branded, Generics, Others), Gender, Route of Administration (Oral, Injectable, Others), Region and Global Forecast 2018-2025.

DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/386032/request-sample

Prominent companies in the industry include Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche, Teva Pharmaceutical Industries, Ltd., GlaxoSmithKline plc, Novartis International AG, Merck & Co. Inc., Amgen Inc, Radius Health, Inc., Novo Nordisk A/S, Actavisplc, GlaxoSmithKline plc, and among others are offering greater opportunities and major players are continuously focused on new product developments and venture capital investments to obtain market share.For instance, in 2018, linigen Group PLC acquired the global rights to osteoporosis drug Imukin from Horizon Pharma PLC. Horizon will retain the rights to Actimmune, a similar drug, in the US, Canada and Japan.

Drug class segment includes bisphosphonates, selective estrogen inhibitors modulator (SERM), parathyroid hormone therapy, calcitonin, rank ligand inhibitors, generics, and others. The bisphosphonates segment held highest market share of 31.08% in 2017. Bisphosphonates are the most commonly prescribed medication for treatment and prevention of osteoporosis. Route of administration segment covers oral, injectable, and others. The oral segment valued around USD 805.72 million in 2017 owing to high preference of oral osteoporosis drugs, ease of availability, and is commonly prescribed medication for treatment. Gender segment consist of male and female. The female segment is anticipated to grow with highest CAGR 6.29% during the forecast period owing to increasing the risk of fractures, mainly in wrist, hip, and spinal vertebrae are seen more in women's over the age of 50. According to International Osteoporosis Foundation (IOF), the number of women suffering from osteoporosis has crossed more than 200 million globally.

BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/osteoporosis-drugs-market-by-drug-class-bisphosphonates-selective-386032.html

Increasing geriatric population, changing lifestyles impinging bone health, increasing the prevalence of osteoporosis in postmenopausal women are the key driving factors for the osteoporosis drugs market. In addition, growing awareness about osteoporotic care, and increasing investment in drug discovery and development will lead the growth of osteoporosis drugs market in couple of years. The side effects of osteoporosis drugs and patent expiration of osteoporosis drugmay limit the growth of market. However, increasing R&D investment in drug discovery and development and increasing healthcare expenditure is expected to boost the osteoporosis drugs market over the forecast period.

Customization of the Report:This report can be customized to meet the client's requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.

Contact Us

Mark Stone
Sales Manager
Office-102, Sanskriti Aspirations
Baner Road, Pune,
MH 411045
India
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

About Us:

Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients' objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. We sell market research reports obtained from major publishers from various industries, in which a comprehensive overview of the market is provided along with statistical forecasts, strategic recommendations, detailed segmentation, current market scenario, competitive landscape and key trends.

This release was published on openPR.